Financial Gravity Asset Management, Inc. Kamada LTD Transaction History

Financial Gravity Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$5.37 - $9.45 $1,949 - $3,430	-363 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$4.56 - $7.13 $13,274 - $20,755	-2,911 Reduced 88.91%	363 $2,000
Q4 2019 Feb 28, 2020	BUY	$4.97 - $7.7 $16,271 - $25,209	3,274 New	3,274 $22,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $264M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.